Overview

Update
IPO / Stock
Went Public on Oct 27, 2005 / NASDAQ:SNSS
Headquarters:
South San Francisco, CA
Description:
Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.
Founders:
Categories:
Pharmaceutical, Health Care, Biotechnology
Website:
http://www.sunesis.com
Social:

Company Details

Update

Sunesis is an emerging biopharmaceutical company creating new medicines to improve the lives of people with cancer. They are building a pipeline of drugs that selectively block critical mechanisms required for tumor growth and survival. The fight against cancer is an enormous mission that requires an integrated approach fueled by a commitment to innovation.

Funding Rounds (2) - $58.5M

Update
DateAmount / RoundValuationLead InvestorInvestors
Apr, 2016$15M / Post Ipo Debt0
Apr, 2009$43.5M / Post Ipo Equity9

Current Team (1)

Update

Board Members and Advisors (4)

Update

Offices/Locations (1)

Update
  • Headquarters

    395 Oyster Point Boulevard

    Suite 400

    South San Francisco, CA 94080

    USA

Past Team (7)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos